JP2025503397A5 - - Google Patents

Info

Publication number
JP2025503397A5
JP2025503397A5 JP2024534108A JP2024534108A JP2025503397A5 JP 2025503397 A5 JP2025503397 A5 JP 2025503397A5 JP 2024534108 A JP2024534108 A JP 2024534108A JP 2024534108 A JP2024534108 A JP 2024534108A JP 2025503397 A5 JP2025503397 A5 JP 2025503397A5
Authority
JP
Japan
Prior art keywords
nucleotides
dsrna agent
mylip
dsrna
nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534108A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025503397A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081113 external-priority patent/WO2023108020A2/en
Publication of JP2025503397A publication Critical patent/JP2025503397A/ja
Publication of JP2025503397A5 publication Critical patent/JP2025503397A5/ja
Pending legal-status Critical Current

Links

JP2024534108A 2021-12-07 2022-12-07 ＭＹＬＩＰをサイレンシングするためのｉＲＮＡ組成物および方法 Pending JP2025503397A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163286891P 2021-12-07 2021-12-07
US63/286,891 2021-12-07
US202263341885P 2022-05-13 2022-05-13
US63/341,885 2022-05-13
PCT/US2022/081113 WO2023108020A2 (en) 2021-12-07 2022-12-07 iRNA COMPOSITIONS AND METHODS FOR SILENCING MYLIP

Publications (2)

Publication Number Publication Date
JP2025503397A JP2025503397A (ja) 2025-02-04
JP2025503397A5 true JP2025503397A5 (https=) 2025-12-11

Family

ID=86731386

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024534108A Pending JP2025503397A (ja) 2021-12-07 2022-12-07 ＭＹＬＩＰをサイレンシングするためのｉＲＮＡ組成物および方法

Country Status (4)

Country Link
US (1) US20250051767A1 (https=)
EP (1) EP4444885A2 (https=)
JP (1) JP2025503397A (https=)
WO (1) WO2023108020A2 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003295600A1 (en) * 2002-11-14 2004-06-15 Dharmacon, Inc. Functional and hyperfunctional sirna
WO2011091396A1 (en) * 2010-01-25 2011-07-28 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of mylip/idol gene
US20210332367A1 (en) * 2018-09-18 2021-10-28 Alnylam Pharmaceuticals, Inc. KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Similar Documents

Publication Publication Date Title
JP7476422B2 (ja) Ｌｐａ発現を阻害するための組成物及び方法
TWI880645B (zh) 抑制lpa之基因表現之組合物及方法
CN111343994B (zh) 用于抑制血管生成素-样3 (ANGPTL3)的表达的RNAi剂和组合物以及使用方法
CN110268060B (zh) α-1抗胰蛋白酶(AAT)RNAi物质、包含AAT RNAi物质的组合物和使用方法
TWI908388B (zh) 靶向調控PCSK9基因表達的siRNA及其應用
ES2471978T3 (es) Compuestos y procedimientos para modular la expresión de ApoB
JP2021518125A5 (https=)
CN111107853A (zh) 用于抑制载脂蛋白C-III (APOC3)的表达的RNAi试剂和组合物
JP2018530529A5 (https=)
JP7707065B2 (ja) Ａｎｇｐｔｌ８を阻害するための新規のｒｎａ組成物および方法
CN116490195A (zh) 用于抑制脂蛋白(a)的RNA组合物和方法
JP2023514336A5 (https=)
JP2023546103A (ja) Ａｎｇｐｔｌ３を阻害するための新規のｒｎａ組成物および方法
JP2024538859A5 (https=)
JP2024528701A5 (https=)
CN114555188A (zh) 治疗apoc3相关疾病和病症的方法
CN120505318B (zh) LSR、LncRNA-LSR-AS1或靶向siRNA在预防和/或治疗高脂血症或其相关疾病中的应用
CN120118909A (zh) 靶向调控LPA基因表达的siRNA双链体及其在预防和治疗心脑血管相关疾病中的用途
CN114716518A (zh) 一种能够抑制pcsk9表达的分子构造及药物组合物
WO2025103391A1 (zh) 用于抑制lpa的基因表达的sirna，含其的组合物及其用途
JP2025503397A5 (https=)
WO2011038700A1 (zh) Fam3b基因的抑制剂和抑制剂组合物及抑制方法以及抑制剂在制药中的应用
JP7412668B2 (ja) アンチセンスオリゴヌクレオチド複合体
EP4678747A2 (en) Double-stranded rnai agents for targeting and regulating hbv gene expression, and a use thereof
US20260125681A1 (en) DOUBLE-STRANDED RNAi AGENTS FOR TARGETING AND REGULATING HBV GENE EXPRESSION, AND A USE THEREOF